论文部分内容阅读
克塞灵(降纤酶)为近年来应用于临床的强力单成分溶血栓治剂,主要用于急性缺血性脑血管疾病的治疗。我院从1997年9月起进行了克塞灵和低分子右旋糖酐加丹参治疗急性脑梗塞的疗效对比观察,现总结如下:1 观察对象克塞灵组(治疗组)共30例,年龄为31～70岁,平均60岁,对照组(低分子右
Kesselin (defibrase) is a powerful single-component thrombolytic agent used clinically in recent years and is mainly used for the treatment of acute ischemic cerebrovascular diseases. Our hospital from September 1997 on the implementation of ketose and low molecular weight dextran plus salvia miltiorrhiza treatment of acute cerebral infarction comparison of efficacy, are summarized as follows: 1 observed objects xase Ling group (treatment group) a total of 30 patients, age 31 ~ 70 years old, average 60 years old, control group (low molecular right